Patent ID: 11951110
Assignee: WISTA LABORATORIES LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 0:
1. A method of treatment of a disease in a subject in need thereof,
wherein said disease is selected from the group consisting of: skin cancer, Hepatitis C, HIV, West Nile Virus (WNV), and malaria,
the method comprising administering to the subject with the disease a therapeutically effective amount of a bis protic acid salt compound of the following formula:, wherein:
each of R1 and R9 is independently selected from: —H, C1-4alkyl, C2-4alkenyl, and halogenated C1-4alkyl;
each of R3NA and R3NB is independently selected from: —H, C1-4alkyl, C2-4alkenyl, and halogenated C1-4alkyl;
each of R7NA and R7NB is independently selected from: —H, C1-4alkyl, C2-4alkenyl, and halogenated C1-4alkyl; and
each of HX1 and HX2 is independently a protic acid, wherein if any of HX1 or HX2 is a hydrohalic acid, then each is independently selected from HCl and HBr.